Cardiology (all articles)
M-A | Association of SGLT2 inhibitors with cardiovascular outcomes and safety events.
1 Nov, 2022 | 11:56h | UTC
ACC Expert consensus for integrating atherosclerotic cardiovascular disease and multimorbidity treatment.
31 Oct, 2022 | 13:59h | UTC
Commentary on Twitter
.@ACCinTouch's newest Expert Consensus Decision Pathway, just published in #JACC, offers a comprehensive and integrative framework for treating patients with #ASCVD and multimorbidity. https://t.co/NAa1aP4OEx#ACCClinicalDoc #CardioTwitter @kofi_larry @virani_md @tygluckman pic.twitter.com/XPePHSwuFL
— JACC Journals (@JACCJournals) October 25, 2022
Dose-reduced direct oral anticoagulants: practical considerations.
31 Oct, 2022 | 13:52h | UTC
Consensus Paper | Diagnosis and management of syncope in hypertrophic cardiomyopathy.
31 Oct, 2022 | 13:49h | UTC
Review | Optimal perfusion targets in cardiogenic shock.
31 Oct, 2022 | 13:45h | UTCOptimal Perfusion Targets in Cardiogenic Shock – JACC: Advances
Commentary on Twitter
#CardiogenicShock (CS) carries marked morbidity and mortality, w/ limited data to guide hemodynamic targets. Randomized #clinicaltrials in CS subsets are necessary to better elucidate optimal #perfusion targets. https://t.co/XpmXmlMdww#JACCAdvances #resuscitation #CardioTwitter pic.twitter.com/VWDEYkQ3nm
— JACC Journals (@JACCJournals) July 4, 2022
Evolving presentation of cardiogenic shock: a review of the medical literature and current practices.
31 Oct, 2022 | 13:46h | UTC
Commentary on Twitter
#CardiogenicShock remains a leading cause of morbidity and mortality among patients with #CardiovascularDisease. In his review, authors sought to survey the medical literature and provide an update on current practice. Read this in full here: https://t.co/lA0Hj9PWaM pic.twitter.com/Vz63n5pWfL
— Cardiology and Therapy (@Cardio_Therapy) August 8, 2022
Cohort Study | Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation.
31 Oct, 2022 | 13:42h | UTC
Commentary on Twitter
New study shows that a subset of HFrEF patients without atrial fibrillation have a stroke risk equivalent to that of patients with AF who are not anticoagulatedhttps://t.co/AXM5ut2SUV#stroke #heartfailure #HF #cardiotwitter @ESC_Journals @escardio pic.twitter.com/Ppa17U79b8
— EHJ Editor-in-Chief (@ehj_ed) August 26, 2022
Under a https://creativecommons.org/licenses/by-nc/4.0/ license
Cohort Study | Association of retinal age gap with arterial stiffness and incident cardiovascular disease.
31 Oct, 2022 | 13:32h | UTCAssociation of Retinal Age Gap With Arterial Stiffness and Incident Cardiovascular Disease – Stroke
Related:
RCT | Pulmonary vein isolation plus individualized substrate ablation of atrial low-voltage myocardium reduced A-fib recurrence.
28 Oct, 2022 | 13:24h | UTCLow-Voltage Myocardium-Guided Ablation Trial of Persistent Atrial Fibrillation – NEJM Evidence
Commentary on Twitter
Original Article: “Low-Voltage Myocardium-Guided Ablation Trial of Persistent Atrial Fibrillation,” by @YanHuo2022 et al. https://t.co/OYqzAt7ks0#CardioTwitter #AFib #MedTwitter @tudresden_de @ThomasGaspar16 @purerfellner @EPyoungstar @UKSH_KI_HL @MedUni_Wien @KardiologieWien pic.twitter.com/0ly3pjNiPa
— NEJM Evidence (@NEJMEvidence) October 24, 2022
AHA Scientific Statement | Physician wellness in academic cardiovascular medicine.
27 Oct, 2022 | 12:34h | UTCTop Things to Know: Physician Wellness in Academic CV Medicine – American Heart Association
Commentaries:
Physician Wellness in Academic Cardiovascular Medicine: Key Points – American College of Cardiology
Review | Iron deficiency and cardiovascular disease.
27 Oct, 2022 | 12:31h | UTCIron deficiency and cardiovascular disease – European Heart Journal
Commentary on Twitter
#Iron deficiency and #cardiovascular disease. Great review in @ESC_Journals #CardioTwitter
? https://t.co/339s3LpPmk pic.twitter.com/0wHNHc6xEg
— Enrique Santas (@SantasEnrique) October 26, 2022
Under a https://creativecommons.org/licenses/by-nc/4.0/ license
Cohort Study | Cannabis, cocaine, methamphetamine, and opiates linked to increased risk of incident atrial fibrillation.
27 Oct, 2022 | 12:29h | UTCEditorial: Drug abuse and risk of atrial fibrillation: a neglected association – European Heart Journal
Commentaries:
Marijuana, Meth, Cocaine Use Can Help Trigger Dangerous A-Fib – HealthDay
Commentary on Twitter
New study just published in EHJ suggests that cannabis, cocaine, methamphetamine, and opiates may increase the risk of incident atrial fibrillation: discover more!https://t.co/ySrmaLnacC#AF #methamphetamine #cocaine #opiate #cannabis #cardiotwitter @escardio @ESC_Journals pic.twitter.com/YCvqjPGQjG
— EHJ Editor-in-Chief (@ehj_ed) October 20, 2022
Study commentary | From the management of altitude sickness to congestion in acute HF: a new season for acetazolamide?
27 Oct, 2022 | 12:27h | UTCFrom the management of altitude sickness to treatment of congestion in acute heart failure: a new season for acetazolamide? – European Heart Journal (free for a limited period)
Original study: RCT | Acetazolamide resulted in faster decongestion in patients with acute decompensated heart failure with volume overload.
M-A | Age, sex, race, BMI, and duration of type 2 DM differences in cardiovascular outcomes with glucose lowering drugs.
26 Oct, 2022 | 14:32h | UTCCommentary: Meta-analysis may guide optimal type 2 diabetes glucose-lowering agent for MACE protection – medwire News
New horizons in Type 2 myocardial infarction: pathogenesis, assessment and management of an emerging geriatric disease.
26 Oct, 2022 | 14:27h | UTC
Diaphragmatic function in cardiovascular disease: JACC review topic of the week.
25 Oct, 2022 | 13:22h | UTC
Post-trial follow-up | IV calcium does not improve long-term outcomes in patients with out-of-hospital cardiac arrest.
25 Oct, 2022 | 13:17h | UTCOriginal Study: RCT: Intravenous or intraosseous calcium does not improve the return of spontaneous circulation in adults with out-of-hospital cardiac arrest.
Commentary on Twitter
From the latest issue of @ResusJournal Effect of calcium vs. placebo on long-term outcomes in patients with out-of-hospital cardiac arrest https://t.co/fSCr9DebS7 pic.twitter.com/rRw28GwP5Q
— Emergency Medicine (@ELS_Emerg_Med) September 2, 2022
RCT | Empagliflozin in acute myocardial infarction accompanied by a large creatine kinase elevation.
25 Oct, 2022 | 13:11h | UTCEmpagliflozin in acute myocardial infarction: the EMMY trial – European Heart Journal
Commentary on Twitter
News from EMMY trial: in myocardial infarction, empagliflozin improves NT-proBNP and left ventricular ejection fraction! https://t.co/92WUJRbKuG#myocardial #infarction #empaglifozin #ehj #cardiotwitter @ESC_Journals @escardio pic.twitter.com/XPwowjZrlf
— EHJ Editor-in-Chief (@ehj_ed) September 16, 2022
AHA Scientific Statement | Emerging evidence on coronary heart disease screening in kidney and liver transplantation candidates.
24 Oct, 2022 | 14:11h | UTCTop Things to Know: Emerging Evidence on Coronary Heart Disease (CHD) Screening in Kidney and Liver Transplantation Candidates – American Heart Association
M-A | Coronary perforation incidence, outcomes and temporal trends.
24 Oct, 2022 | 14:10h | UTC
Cohort Study | Highly malignant disease in childhood-onset arrhythmogenic right ventricular cardiomyopathy.
24 Oct, 2022 | 14:08h | UTCEditorial: Arrhythmogenic cardiomyopathies in children: seek and you shall find – European Heart Journal
Commentary on Twitter
Highly malignant disease in childhood-onset arrhythmogenic right ventricular cardiomyopathy: discover more in EHJ!https://t.co/kA60A1zjRt#ARVC #children #screening #heart #transplantation #cardiotwitter @escardio @ESC_Journals pic.twitter.com/fq4X8doBMI
— EHJ Editor-in-Chief (@ehj_ed) September 6, 2022
Under a https://creativecommons.org/licenses/by-nc/4.0/ License
Review | Restrictive cardiomyopathy: definition and diagnosis.
24 Oct, 2022 | 13:58h | UTCRestrictive cardiomyopathy: definition and diagnosis – European Heart Journal
Commentary on Twitter
⚠️Great review ? Restrictive cardiomyopathy
?definition
?diagnosis
?therapies available only for cardiac amyloidosis and, for iron overload cardiomyopath?? https://t.co/OtO7L45SBw pic.twitter.com/L55mPnmNtt
— Alfonso Valle (@ValleAlfonso) October 22, 2022
Under a https://creativecommons.org/licenses/by-nc/4.0/ License
M-A | The optimal timing for non-culprit PCI in patients with multivessel coronary artery disease.
21 Oct, 2022 | 12:52h | UTC
Systematic Review | Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines.
21 Oct, 2022 | 12:47h | UTC
Myocarditis after BNT162b2 vaccination in Israeli adolescents.
20 Oct, 2022 | 12:34h | UTCMyocarditis after BNT162b2 Vaccination in Israeli Adolescents – New England Journal of Medicine
Commentary on Twitter
Among Israeli adolescents between 12 and 15 years of age who received the BNT162b2 vaccine, 9 cases of mild myocarditis were observed, mainly after the second dose. https://t.co/OatYqN4IPD pic.twitter.com/c96d1o7wnt
— NEJM (@NEJM) October 19, 2022